Lacosamide, also known as ADD 243037 and SPM 927, is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. Lacosamide is discontinued (DEA controlled substance).
MedKoo Cat#: 315229
Name: Lacosamide
CAS#: 175481-36-4
Chemical Formula: C13H18N2O3
Exact Mass: 250.1317
Molecular Weight: 250.20
Elemental Analysis: C, 62.38; H, 7.25; N, 11.19; O, 19.18
The following data is based on the product molecular weight 250.20 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
